Dr. Steven E. Hyman is a distinguished member of the Editorial Advisory Board of Psychopharmacology Bulletin and serves as a Core Institute Member and Director of the Program in Brain Health at the Broad Institute of MIT and Harvard. He is also Harvard University Distinguished Service Professor and Harald McPike Professor of Stem Cell and Regenerative Biology.
Research Excellence
From 2012 to 2024, Dr. Hyman served as Director of the Stanley Center for Psychiatric Research at the Broad Institute, where he led groundbreaking research in psychiatric genetics, neurobiology, and drug development. His work focuses on understanding the biological mechanisms underlying psychiatric disorders and developing innovative therapeutic approaches, with particular emphasis on translating genomic discoveries into new treatments for mental illness.
Dr. Hyman has served as editor of the Annual Review of Neuroscience (2002-2016) and has been instrumental in advancing neuroscience research through his leadership roles. His research integrates cutting-edge genomic technologies with neuroscience to identify novel therapeutic targets for psychiatric conditions.
Professional Recognition
Dr. Hyman is a fellow of the American Academy of Arts and Sciences, a fellow of the American Association for the Advancement of Science, a distinguished life fellow of the American Psychiatric Association, and a member of the National Academy of Medicine.
